V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003809 | 210010822 | null | 74.5 | null | 2018-03-06 | 2020-11-27 | Capecitabine | 02 | null | CAPECITABINE | 101688181 |
| 210003811 | 210010823 | 1.67 | 76.2 | Palliative (P) | 2017-02-02 | 2017-02-16 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | N | CAPECITABINE | 100844377 |
| 210003813 | 210010824 | 1.66 | 68.4 | Neo-adjuvant (N) | null | 2021-01-18 | Letrozole + Palbociclib | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101270324 |
| 210003815 | 210010826 | 1.58 | 0 | null | null | 2020-10-07 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100858927 |
| 210003818 | 210010827 | 0 | 71.3 | Adjuvant (A) | null | 2020-05-31 | Palbociclib | null | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101420244 |
| 210003821 | 210010829 | 1.7 | 50.2 | Palliative (P) | 2019-10-01 | 2020-01-22 | Capecitabine | 02 | N | CAPECITABINE | 101309940 |
| 210003826 | 210010832 | 1.63 | 44.4 | Palliative (P) | null | 2020-02-05 | CONCEPT Trial | 02 | N | CARBOPLATIN + DOCETAXEL | 101339951 |
| 210003828 | 210010833 | 1.64 | 63.8 | Adjuvant (A) | 2019-03-19 | 2019-03-31 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101679686 |
| 210003829 | 210010834 | null | 63.2 | null | 2018-12-10 | 2018-12-23 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 100506263 |
| 210003830 | 210010835 | 1.62 | 82.5 | Palliative (P) | null | 2018-08-12 | null | N | N | EC | 101383942 |
| 210003832 | 210010836 | 1.61 | 81.7 | null | null | 2019-03-10 | CAPECITABINE + CARBOPLATIN | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100586130 |
| 210003835 | 210010838 | 1.63 | 65 | Adjuvant (A) | 2016-04-28 | 2016-05-13 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101442024 |
| 210003836 | 210010839 | 1.56 | 53 | null | null | 2020-02-28 | EC + PACLITAXEL | 02 | null | EC | 100323428 |
| 210003838 | 210010841 | 1.56 | 58.7 | Neo-adjuvant (N) | 2021-08-02 | 2021-10-07 | Paclitaxel albumin (Abraxane) 7 day | 02 | N | CISPLATIN + FLUOROURACIL | 101607323 |
| 210003844 | 210010842 | 1.54 | 63.2 | Adjuvant (A) | 2020-09-19 | 2020-09-30 | Pertuzumab (Maintenance) | 01 | N | PERTUZUMAB | 100348651 |
| 210003845 | 210010843 | 1.68 | 95 | null | 2021-08-21 | 2021-11-15 | Capecitabine | null | null | CAPECITABINE | 100474186 |
| 210003846 | 210010844 | 1.58 | 72.1 | Neo-adjuvant (N) | 2016-01-13 | 2016-04-06 | FEC + DOCETAXEL | 02 | N | PALBOCICLIB | 101408426 |
| 210003848 | 210010845 | 1.75 | 67 | Adjuvant (A) | 2018-08-08 | 2018-08-09 | null | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100349970 |
| 210003852 | 210010849 | 1.55 | 42.9 | Palliative (P) | 2014-03-04 | 2018-07-03 | PACLITAXEL + TRASTUZUMAB | 02 | N | CARBOPLATIN + DOCETAXEL | 100647356 |
| 210003855 | 210010851 | 1.67 | 58.3 | Adjuvant (A) | 2021-02-08 | 2022-05-18 | null | null | N | PACLITAXEL + TRASTUZUMAB | 101448000 |
| 210003857 | 210010852 | 1.77 | 67.4 | null | 2018-08-19 | 2019-03-13 | Trial Unspecified | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 100064061 |
| 210003858 | 210010853 | 0 | 78.65 | null | 2016-04-02 | 2016-08-05 | TCH (21 day Trastuzumab) Maint | 01 | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 101594501 |
| 210003859 | 210010854 | 1.63 | 84.8 | null | 2019-01-31 | 2019-04-12 | Abemaciclib | null | null | NAB-PACLITAXEL | 100934002 |
| 210003862 | 210010855 | 1.61 | 94 | Palliative (P) | 2019-11-22 | 2019-11-23 | Capecitabine | 02 | N | EC | 100376955 |
| 210003864 | 210010857 | 1.62 | null | Palliative (P) | null | 2019-03-24 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100309071 |
| 210003865 | 210010858 | 1.64 | 104.5 | Neo-adjuvant (N) | null | 2021-03-25 | Capecitabine | 01 | N | CAPECITABINE | 100337928 |
| 210003866 | 210010859 | 1.65 | 68.8 | Palliative (P) | 2019-11-20 | 2019-12-04 | null | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100727861 |
| 210003868 | 210010860 | 1.56 | 58 | Palliative (P) | 2019-11-11 | 2020-05-04 | Carboplatin AUC 2 - 5 | N | N | CARBOPLATIN | 100115007 |
| 210003869 | 210010861 | 1.71 | 80.4 | null | 2017-04-30 | 2017-05-26 | FEC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100691336 |
| 210003870 | 210010862 | 1.62 | 77.8 | null | 2019-04-19 | 2019-09-27 | Capecitabine | 02 | null | CAPECITABINE | 101050368 |
| 210003872 | 210010864 | 1.71 | 78 | Neo-adjuvant (N) | 2021-04-06 | 2021-04-13 | Capecitabine | 02 | N | CAPECITABINE | 100048535 |
| 210003873 | 210010865 | null | null | Adjuvant (A) | null | 2017-03-08 | ROSCO Trial | 02 | null | CARBOPLATIN + GEMCITABINE | 101698165 |
| 210003874 | 210010866 | 1.73 | 89.1 | Adjuvant (A) | 2019-04-24 | 2019-05-15 | null | null | N | PACLITAXEL + TRASTUZUMAB | 101181685 |
| 210003877 | 210010868 | 1.74 | 81 | null | null | 2017-03-12 | Doce + Pertuzumab + Trastuz IV Load | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100632156 |
| 210000002 | 210010871 | null | null | null | 2016-12-23 | 2019-10-09 | null | 02 | null | GEMCARBO | 101666120 |
| 210000022 | 210010872 | 1.72 | 71 | Adjuvant (A) | 2022-01-17 | 2022-02-11 | Carboplatin + Docetaxel | 02 | N | TIVOZANIB | 100160192 |
| 210000062 | 210010874 | 1.64 | 56.2 | Neo-adjuvant (N) | null | 2018-10-22 | FEC | 02 | N | PACLITAXEL + TRASTUZUMAB | 100225173 |
| 210000169 | 210010875 | 1.75 | 42.9 | null | 2019-09-04 | 2019-09-19 | null | 02 | null | ATEZOLIZUMAB | 101740701 |
| 210000406 | 210010879 | 1.69 | null | Adjuvant (A) | 2019-06-20 | 2019-06-20 | null | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101185927 |
| 210000562 | 210010880 | 1.51 | 80.5 | null | 2021-01-09 | 2021-08-05 | null | 02 | null | ROSCO TRIAL | 101698914 |
| 210000730 | 210010881 | 1.66 | 51.5 | Adjuvant (A) | 2019-11-10 | 2019-11-30 | null | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100737972 |
| 210000836 | 210010883 | 1.84 | 88.5 | Adjuvant (A) | 2017-03-18 | 2017-04-09 | Capecitabine | 02 | N | CAPECITABINE | 101689281 |
| 210000892 | 210010884 | null | 85.2 | Neo-adjuvant (N) | 2017-01-02 | 2017-04-07 | CISPLATIN + ETOPOSIDE | null | N | EC | 100248794 |
| 210001109 | 210010887 | null | null | Palliative (P) | 2018-04-10 | 2018-04-10 | null | null | N | PALBOCICLIB | 100904517 |
| 210001120 | 210010888 | 1.75 | 72.3 | null | 2018-07-16 | 2018-07-16 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100823922 |
| 210001126 | 210010889 | 1.67 | 83.6 | Adjuvant (A) | null | 2019-01-21 | Capecitabine | 01 | N | TRIAL UNSPECIFIED | 101674658 |
| 210001177 | 210010890 | null | 80.8 | Adjuvant (A) | 2020-01-15 | 2020-02-28 | Capecitabine | N | N | EC | 101683789 |
| 210001373 | 210010893 | 1.79 | 53 | Neo-adjuvant (N) | 2019-03-28 | 2019-04-18 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101373807 |
| 210001443 | 210010895 | null | null | null | 2018-09-09 | 2018-10-27 | EC | null | null | EC | 100966119 |
| 210001764 | 210010899 | 1.66 | 96 | Palliative (P) | null | 2018-07-28 | null | 02 | N | TRIAL UNSPECIFIED | 101177904 |